Biotech News
Veradigm Extends Stockholder Rights Plan
investor.veradigm.com2026-05-06 14:53 EST
CHICAGO --(BUSINESS WIRE)--Feb. 2, 2026-- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to